Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Single Cell Analysis Market 2016-2022: Market is Estimated to Grow at CAGR of 18.5% - Research and Markets

Research and Markets
Posted on: 01 Nov 16

Research and Markets has announced the addition of the "Global Single Cell Analysis Market, company profiles, share, trends, analysis, opportunities, segmentation and forecast 2016 - 2022" report to their offering.

The global single cell analysis market is estimated to grow at CAGR of 18.5% during 2016-2022.

The single cell analysis is segmented on the basis of application, cell type, product, end user, technique and geography. The application segment is segmented into research application and medical application. The end user segment is also segmented into biotechnology and biopharmaceutical companies, cell banks and IVF centers, hospitals and diagnostic laboratories and research & academic laboratories. The cell type segment is segmented into animal cells, human cells and microbial cells.

The single cell analysis market is majorly driven by a growing geriatric population and prevalence of chronic diseases is increasing the scope of single cell analysis in the global market. However, the unwillingness among researchers to accept advanced single-cell analysis products and stringent government policies may hinder the growth in the global single cell analysis market.

The global single cell analysis market is having huge opportunities such as huge growth opportunity in the emerging countries, growth potential in single-cell sequencing (SCS), fostering stem cell research is expected to contribute a lot in the growth of global single cell analysis market and the untapped Asia pacific region has a huge scope for single cell analysis market.

The single cell analysis market is dominated by some of the major key players such as Becton, Dickinson and Company, Bioheart, Corning, Inc., Medtronic PLC, Celgene Corporation, GE Healthcare, Illumina Inc., Merck KGAA, Nanostring technologies Inc., Stem cell Technologies, Stryker Corporation, Thermo Fisher Scientific, Inc.

In 2015, Medtronic announced that they had completed the acquisition of Covidien plc. which was an Irish-headquartered global health care products company and manufacturer and supplier of medical devices.

For more information about this report visit http://www.researchandmarkets.com/research/djk65r/global_single

View source version on businesswire.com: http://www.businesswire.com/news/home/20161101006490/en/

Business Wire
www.businesswire.com

Last updated on: 01/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.